Nuclear factor kappa B expression in non-small cell lung cancer

In this mini-review, we discuss the role of NF-κB, a proinflammatory transcription factor, in the expression of genes involved in inflammation, proliferation, and apoptosis pathways, and link it with prognosis of various human cancers, particularly non-small cell lung cancer (NSCLC). We and others h...

Full description

Bibliographic Details
Main Authors: Leilei Zhang, Claudia M. Ludden, Alexander J. Cullen, Kenneth D. Tew, André Luís Branco de Barros, Danyelle M. Townsend
Format: Article
Language:English
Published: Elsevier 2023-11-01
Series:Biomedicine & Pharmacotherapy
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S075333222301257X
_version_ 1797660580399546368
author Leilei Zhang
Claudia M. Ludden
Alexander J. Cullen
Kenneth D. Tew
André Luís Branco de Barros
Danyelle M. Townsend
author_facet Leilei Zhang
Claudia M. Ludden
Alexander J. Cullen
Kenneth D. Tew
André Luís Branco de Barros
Danyelle M. Townsend
author_sort Leilei Zhang
collection DOAJ
description In this mini-review, we discuss the role of NF-κB, a proinflammatory transcription factor, in the expression of genes involved in inflammation, proliferation, and apoptosis pathways, and link it with prognosis of various human cancers, particularly non-small cell lung cancer (NSCLC). We and others have shown that NF-κB activity can be impacted by post-translational S-glutathionylation through reversible formation of a mixed disulfide bond between its cysteine residues and glutathione (GSH). Clinical data analysis showed that high expression of NF-κB correlated with shorter overall survival (OS) in NSCLC patients, suggesting a tumor promotion function for NF-κB. Moreover, NF-κB expression was associated with tumor stage, lymph node metastasis, and 5-year OS in these patients. NF-κB was over-expressed in the cytoplasm of tumor tissue compared to adjacent normal tissues. S-glutathionylation of NF-κB caused negative regulation by interfering with DNA binding activities of NF-κB subunits. In response to oxidants, S-glutathionylation of NF-κB also correlated with enhanced lung inflammation. Thus, S-glutathionylation is an important contributor to NF-κB regulation and clinical results highlight the importance of NF-κB in NSCLC, where NF-κB levels are associated with unfavorable prognosis.
first_indexed 2024-03-11T18:31:57Z
format Article
id doaj.art-6a59c99872434363a3b346b863248ec3
institution Directory Open Access Journal
issn 0753-3322
language English
last_indexed 2024-03-11T18:31:57Z
publishDate 2023-11-01
publisher Elsevier
record_format Article
series Biomedicine & Pharmacotherapy
spelling doaj.art-6a59c99872434363a3b346b863248ec32023-10-13T11:02:41ZengElsevierBiomedicine & Pharmacotherapy0753-33222023-11-01167115459Nuclear factor kappa B expression in non-small cell lung cancerLeilei Zhang0Claudia M. Ludden1Alexander J. Cullen2Kenneth D. Tew3André Luís Branco de Barros4Danyelle M. Townsend5Department of Cell and Molecular Pharmacology and Experimental Therapeutics, Medical University of South Carolina, Charleston, SC, USADepartment of Drug Discovery and Experimental Sciences, Medical University of South Carolina, Charleston, SC, USADepartment of Drug Discovery and Experimental Sciences, Medical University of South Carolina, Charleston, SC, USADepartment of Cell and Molecular Pharmacology and Experimental Therapeutics, Medical University of South Carolina, Charleston, SC, USADepartment of Clinical and Toxicological Analyses, Faculty of Pharmacy, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, BrazilDepartment of Drug Discovery and Experimental Sciences, Medical University of South Carolina, Charleston, SC, USA; Correspondence to: Departments of Pharmaceutical and Biomedical Sciences, Medical University of South Carolina, 173 Ashley Ave., P.O. Box 250505, Charleston, SC 29425, USA.In this mini-review, we discuss the role of NF-κB, a proinflammatory transcription factor, in the expression of genes involved in inflammation, proliferation, and apoptosis pathways, and link it with prognosis of various human cancers, particularly non-small cell lung cancer (NSCLC). We and others have shown that NF-κB activity can be impacted by post-translational S-glutathionylation through reversible formation of a mixed disulfide bond between its cysteine residues and glutathione (GSH). Clinical data analysis showed that high expression of NF-κB correlated with shorter overall survival (OS) in NSCLC patients, suggesting a tumor promotion function for NF-κB. Moreover, NF-κB expression was associated with tumor stage, lymph node metastasis, and 5-year OS in these patients. NF-κB was over-expressed in the cytoplasm of tumor tissue compared to adjacent normal tissues. S-glutathionylation of NF-κB caused negative regulation by interfering with DNA binding activities of NF-κB subunits. In response to oxidants, S-glutathionylation of NF-κB also correlated with enhanced lung inflammation. Thus, S-glutathionylation is an important contributor to NF-κB regulation and clinical results highlight the importance of NF-κB in NSCLC, where NF-κB levels are associated with unfavorable prognosis.http://www.sciencedirect.com/science/article/pii/S075333222301257XNFkBLung cancerP65P50Redox regulationGlutathionylation
spellingShingle Leilei Zhang
Claudia M. Ludden
Alexander J. Cullen
Kenneth D. Tew
André Luís Branco de Barros
Danyelle M. Townsend
Nuclear factor kappa B expression in non-small cell lung cancer
Biomedicine & Pharmacotherapy
NFkB
Lung cancer
P65
P50
Redox regulation
Glutathionylation
title Nuclear factor kappa B expression in non-small cell lung cancer
title_full Nuclear factor kappa B expression in non-small cell lung cancer
title_fullStr Nuclear factor kappa B expression in non-small cell lung cancer
title_full_unstemmed Nuclear factor kappa B expression in non-small cell lung cancer
title_short Nuclear factor kappa B expression in non-small cell lung cancer
title_sort nuclear factor kappa b expression in non small cell lung cancer
topic NFkB
Lung cancer
P65
P50
Redox regulation
Glutathionylation
url http://www.sciencedirect.com/science/article/pii/S075333222301257X
work_keys_str_mv AT leileizhang nuclearfactorkappabexpressioninnonsmallcelllungcancer
AT claudiamludden nuclearfactorkappabexpressioninnonsmallcelllungcancer
AT alexanderjcullen nuclearfactorkappabexpressioninnonsmallcelllungcancer
AT kennethdtew nuclearfactorkappabexpressioninnonsmallcelllungcancer
AT andreluisbrancodebarros nuclearfactorkappabexpressioninnonsmallcelllungcancer
AT danyellemtownsend nuclearfactorkappabexpressioninnonsmallcelllungcancer